Contracts › HT942524F0182
HT942524F0182: The Defense Health Agency Directorate Requires Support to Assist and Enable the Dha to Transition, Implement and Sustain Mature, Priority, Evidence Based Research Into Practice to Optimize Its Impact.
Awarded to Culmen International, Llc by Defense Health Agency.
$8.3Mobligated
$14.2Mpotential value
21 July 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HT942524F0182 |
|---|---|
| Vehicle | HT001122D0053 |
| Awardee | Culmen International, Llc |
| Awarding agency | Defense Health Agency |
| Awarding office | DEFENSE HEALTH AGENCY |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | MD |
| Offers received | 3 |
| Period of performance | 24 June 2024 to 21 July 2027 |
| Potential end | 21 July 2029 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record